forces predisposes the adjacent areas to the breakdown of the cartilage (Bullough and Goodfellow, 1968).
A case ofpersistent positive haemagglutination data for infectious mononucleosis in a patient with rheumatoid arthritis is reported. The haemagglutination data including rapid slide tests as well as antibodies to Epstein-Barr (EB) virus-induced antigens showed little change over a 12-month period.
Tube differential absorption tests with either sheep or horse erythrocytes were performed by standard methods (Lee et al., 1968a; 1968b) . In determining end-points the microscope was used to confirm marginal macroscopic agglutination. Antibodies to EB virus-induced antigens were measured by indirect immunofluorescence techniques (Henle et al., 1968; 1971a; 1971b 
Comment
Despite negative clinical findings when initially examined in April 1971, a mild or even asymptomatic case of infectious mononucleosis could not be completely excluded. The absence of atypical lymphocytes in a seropositive patient does not exclude recent infectious mononucleosis, since morphological changes as well as clinical symptomatology may disappear many months before the disappearance of specific infectious mononucleosis heterophil antibodies. We believe, however, that the relatively unchanged haemagglutination data over the 12-month period represents persistent false positivity for the disease. In addition, this patient had a persistent cold agglutinin that was unusual in that it was reactive against adult 0 (ii) cells, but did not significantly react against cord (ii) erythrocytes.
All of the sera from this patient showed relatively high and persistent titres (1/160) of antibodies to EB viral capsid antigens. Such high and persistent anti-viral capsid antigen titres have been recorded frequently in Burkitt's lymphoma and nasopharyngeal carcinoma, less frequently in other malignancies, systemic lupus erythematosus, sarcoidosis, and occasionally in healthy blood donors (5-15%) (Henle et al., 1968; 1971a; 1971b; Evans, 1971) . Antibodies to EB virus-induced early antigens are detected in about 75% of cases of infectious mononucleosis depending in part on the severity of illness (Henle et al., 1971a) . Since these antibodies usually appear later than anti-viral capsid antigens and disappear again after a few months, they often are of diagnostic significance. Antibodies to EB virus-induced early antigens have also been detected in many patients with Burkitt's lymphoma and nasopharyngeal carcinoma and, less frequently, in other conditions, and often persist (Henle et al., 1971a; 1971b) . (Cabrera and Carlson, 1970) . t Antibody titres to Epstein-Barr virus-induced antigens include viral capsid antigens (VCA) and the "D" and "R" subgroups of early induced EB virus antigens (EA). $ Cold agglutinins (anti-i) reactive against 0 (ii) adult cells; no significant agglutination (4°C) against adult (II) and cord red blood cells. § Normal adult serum macroglobulin (IgM) levels 100 ± 55 mg/100 ml. Recently it was noted that antibodies to EB virus-induced early antigens yield two distinct patterns of immunofluorescence in abortively EB virus-infected Raji cells (Henle et al., 1971b) . One pattern ("D"), generally found in infectious mononucleosis, shows diffuse staining of both nucleus and cytoplasm of target cells. The other pattern ("R") is restricted to a cytoplasmic mass in the target cells and is seen especially in patients with Burkitt's lymphoma. Patients with nasopharyngeal carcinoma show predominantly anti-D patterns with low anti-R reactivity (Henle et al., 1971b) . In general, the R pattern is found in chronic disease states rather than in acute primary EB virus infections. In the present case low titre antibodies to EB virusinduced early antigens of the R type alone were barely detectable in 1/10 dilutions in four out of eight samples.
Persistently raised levels of antibodies to EB virus-related antigens may reflect endogenous reactivation ofa latent persistent viral carrier state, which regularly follows primary EB virus infections (Evans, 1971; Smith and Bausher, 1972) . The level and frequency of such raised titres varies from condition to condition and may reflect the extent of viral activity. According to Evans (1971) a spectrum of host responses may occur in association with endogenous EB virus reactivation. This may result in raised antibody titres but only mild symptoms referable to EB virus infections. Such a reactivation would be expected in diseases associated with a decline in cell-mediated immunity and defects in immunological surveillance (Evans, 1971) .
